China Pharma Holdings (CPHI) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q1 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $18.1 million versus the consensus estimate of $18 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance
- Idaho Strategic Resources, Inc. (IDR) Misses Q2 EPS by 4c
- Brookfield Corporation (BN) Misses Q2 EPS by 51c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
